HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties.

Abstract
Episodic ataxia type 1 (EA-1) is a neurological disorder arising from mutations in the Kv1.1 potassium channel alpha-subunit. EA-1 patients exhibit substantial phenotypic variability resulting from at least 14 distinct EA-1 point mutations. We found that EA-1 missense mutations generate mutant Kv1.1 subunits with folding and intracellular trafficking properties indistinguishable from wild-type Kv1.1. However, the single identified EA-1 nonsense mutation exhibits intracellular aggregation and detergent insolubility. This phenotype can be transferred to co-assembled Kv1 alpha- and Kv beta-subunits associated with Kv1.1 in neurons. These results suggest that as in many neurodegenerative disorders, intracellular aggregation of misfolded Kv1.1-containing channels may contribute to the pathophysiology of EA-1.
AuthorsL N Manganas, S Akhtar, D E Antonucci, C R Campomanes, J O Dolly, J S Trimmer
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 276 Issue 52 Pg. 49427-34 (Dec 28 2001) ISSN: 0021-9258 [Print] United States
PMID11679591 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • KCNA1 protein, human
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Ubiquitin
  • Vimentin
  • Kv1.1 Potassium Channel
Topics
  • Animals
  • Ataxia (genetics, physiopathology)
  • COS Cells
  • Humans
  • Kv1.1 Potassium Channel
  • Mutation
  • Neurons (physiology)
  • Phenotype
  • Potassium Channels (chemistry, genetics, metabolism)
  • Potassium Channels, Voltage-Gated
  • Protein Folding
  • Protein Transport (physiology)
  • Rats
  • Ubiquitin (metabolism)
  • Vimentin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: